Elizabeth has worked at the intersection of international investment and commercialization within healthcare for the last 15 years, spanning 28 countries and all classes of complexity, building a reputation for strategic risk management for both investors and companies.
She is on the Board of Directors of a business angel network, SWAN Impact, where she focuses on impact-driven healthcare startup investments. Leveraging experience as a senior executive at startups through large public companies while living in Europe and South America, she is a Managing Partner at Venture Atlas Labs, a commercialization firm that supports global companies in US market success alongside investors, government agencies, and innovation centres.
She has worked in global innovation at the leading university in Texas, and she serves as a US federal grant reviewer for medical devices, an advisor to numerous accelerators, and is a frequent keynote speaker.